Marco Gattorno Selected Research

Matrix Metalloproteinases (MMPs)

8/2002	Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.
4/2002	Serum and synovial fluid concentrations of matrix metalloproteinases 3 and its tissue inhibitor 1 in juvenile idiopathic arthritides.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Gattorno Research Topics

Disease

37	Inflammation (Inflammations) 01/2023 - 05/2008
23	Fever (Fevers) 01/2024 - 03/2005
18	Cryopyrin-Associated Periodic Syndromes 01/2022 - 09/2007
15	Mevalonate Kinase Deficiency 11/2023 - 05/2008
15	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 10/2004
13	Pericarditis 01/2023 - 01/2009
12	Familial Mediterranean Fever (Periodic Disease) 11/2023 - 05/2008
12	Arthritis (Polyarthritis) 08/2019 - 04/2002
8	autosomal dominant familial Periodic fever 09/2023 - 03/2006
7	Acquired Immunodeficiency Syndrome (AIDS) 01/2023 - 12/2014
7	COVID-19 01/2023 - 07/2020
7	Necrosis 01/2022 - 05/2013
6	Exanthema (Rash) 10/2023 - 07/2006
6	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2021 - 05/2013
5	Bites and Stings (Sting) 11/2023 - 01/2017
5	Hypoxia (Hypoxemia) 01/2017 - 06/2008
4	Lymphadenitis (Adenitis) 11/2023 - 05/2013
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 09/2010
4	Macrophage Activation Syndrome 10/2022 - 01/2020
4	Lymphadenopathy 01/2022 - 05/2008
3	Vasculitis (Vasculitides) 12/2023 - 01/2021
3	Aphthous Stomatitis (Aphthous Ulcer) 11/2023 - 04/2018
3	Abdominal Pain (Pain, Abdominal) 10/2022 - 08/2019
3	Lupus Nephritis 10/2021 - 03/2002
3	Agammaglobulinemia (Hypogammaglobulinemia) 10/2021 - 01/2017
3	Stroke (Strokes) 01/2021 - 07/2006
3	Hereditary Autoinflammatory Diseases 01/2018 - 11/2009
3	Acne Vulgaris 01/2016 - 05/2013
2	Virus Diseases (Viral Diseases) 02/2024 - 01/2022
2	Polyarteritis Nodosa (Periarteritis Nodosa) 12/2023 - 11/2022
2	Pharyngitis (Sore Throat) 11/2023 - 05/2013
2	Rheumatoid Arthritis 09/2023 - 01/2018
2	Heart Diseases (Heart Disease) 08/2023 - 08/2022
2	Rheumatic Diseases (Rheumatism) 01/2023 - 08/2002
2	Simian Acquired Immunodeficiency Syndrome 01/2023 - 11/2015
2	Lung Diseases (Lung Disease) 10/2022 - 07/2020
2	Arthralgia (Joint Pain) 10/2022 - 01/2022
2	Myocarditis (Carditis) 08/2022 - 01/2018
2	Proteostasis Deficiencies 01/2022 - 01/2020
2	Dermatitis 01/2022 - 08/2019
2	Reinfection 01/2022 - 10/2021
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 12/2020
2	Tonsillitis 01/2022 - 01/2017
2	chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 01/2022 - 01/2022
2	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021 - 01/2017
2	Pneumonia (Pneumonitis) 10/2021 - 01/2021
2	Lymphopenia (Lymphocytopenia) 10/2021 - 11/2018
2	Schmid-Fraccaro syndrome 09/2021 - 09/2016
2	hyperzincemia and hypercalprotectinemia 01/2021 - 11/2015
2	Cytokine Release Syndrome 01/2021 - 01/2020
2	Infectious Mononucleosis (Glandular Fever) 12/2020 - 01/2017
2	Dermatomyositis (Dermatopolymyositis) 01/2020 - 07/2005

Drug/Important Bio-Agent (IBA)

24	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 08/2023 - 09/2007
17	Interleukin-1 (Interleukin 1)IBA 01/2023 - 09/2007
17	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
15	Colchicine FDA LinkGeneric 01/2024 - 06/2014
11	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 04/2024 - 09/2007
11	canakinumab FDA Link 09/2023 - 02/2013
11	CytokinesIBA 01/2023 - 10/2004
11	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2014
9	InflammasomesIBA 06/2024 - 01/2011
9	AutoantibodiesIBA 01/2023 - 09/2010
9	Adenosine DeaminaseIBA 11/2022 - 09/2016
7	InterleukinsIBA 01/2023 - 12/2011
7	C-Reactive ProteinIBA 01/2022 - 11/2016
6	InterferonsIBA 11/2023 - 09/2010
6	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2022 - 04/2011
5	SteroidsIBA 01/2023 - 11/2012
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2006
4	PyrinIBA 01/2024 - 11/2015
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2023 - 05/2008
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 09/2010
4	NLR ProteinsIBA 10/2022 - 05/2010
4	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2014
3	Interferon Type IIBA 11/2023 - 01/2017
3	AlarminsIBA 01/2023 - 11/2015
3	LigandsIBA 01/2023 - 01/2017
3	AntibodiesIBA 10/2021 - 07/2006
3	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2021 - 11/2015
3	Proline (L-Proline)FDA Link 01/2021 - 11/2015
3	Interleukin-1beta (Interleukin 1 beta)IBA 11/2009 - 09/2007
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2023
2	Immunoglobulin A (IgA)IBA 12/2023 - 01/2022
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2023 - 01/2017
2	S100A12 ProteinIBA 01/2023 - 06/2014
2	Notch ReceptorsIBA 01/2023 - 04/2022
2	Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA 10/2022 - 01/2022
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2022 - 11/2018
2	rilonacept FDA Link 01/2022 - 07/2021
2	Antiviral Agents (Antivirals)IBA 12/2021 - 07/2006
2	Transaminases (Aminotransferases)IBA 10/2021 - 11/2016
2	Adalimumab (Humira)FDA Link 01/2021 - 09/2016
2	Methylprednisolone FDA LinkGeneric 01/2021 - 01/2021
2	Interleukin-18 (Interleukin 18)IBA 01/2020 - 05/2008
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 08/2019 - 06/2017

Therapy/Procedure

22	Therapeutics 10/2022 - 03/2002
4	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2015
2	Stem Cell Transplantation 10/2021 - 07/2021